How does USPSTF determine when to update recommendations?

• A. Only when there is a major new drug approval.
• B. Through systematic reviews and ongoing updates as new evidence emerges.
• C. Every five years regardless of new evidence.
• D. Only when requested by policymakers.

Answer: (B)

Updates are driven by new evidence, found and evaluated through systematic reviews and ongoing surveillance of the literature. The USPSTF does not follow a fixed timetable; when high-quality new studies or data change the balance of benefits and harms, they update or revise the recommendation accordingly. This living evidence approach keeps guidance aligned with the latest research.

That’s why the option describing systematic reviews and ongoing updates as new evidence emerges is the best fit. It’s not limited to major drug approvals, not on a strict five-year schedule, and not contingent on policymakers’ requests—the process hinges on evolving evidence.